Cargando…
Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
Pancreatic cancer is one of the most lethal cancers. Transmembrane 4 superfamily member 5 protein (TM4SF5) is one of the candidate molecular targets used for the prevention and treatment of TM4SF5-expressing cancers, including hepatocellular carcinoma, colon cancer and pancreatic cancer. Recently, a...
Autores principales: | Park, Sangkyu, Kim, Dongbum, Park, Jeong-A, Kwon, Hyung-Joo, Lee, Younghee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924189/ https://www.ncbi.nlm.nih.gov/pubmed/31897180 http://dx.doi.org/10.3892/ol.2019.11134 |
Ejemplares similares
-
A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
por: Park, Sangkyu, et al.
Publicado: (2018) -
Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model
por: Kim, Young-Eun, et al.
Publicado: (2014) -
Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model
por: Wu, Guang, et al.
Publicado: (2016) -
Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023) -
Prevention and Therapy of Hepatocellular Carcinoma by Vaccination with TM4SF5 Epitope-CpG-DNA-Liposome Complex without Carriers
por: Kwon, Sanghoon, et al.
Publicado: (2012)